These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 27795365

  • 21. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
    Baldwin MR, Barbieri JT.
    Biochemistry; 2007 Mar 20; 46(11):3200-10. PubMed ID: 17311420
    [Abstract] [Full Text] [Related]

  • 22. Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6.
    Moritz MS, Tepp WH, Bradshaw M, Johnson EA, Pellett S.
    mSphere; 2018 Oct 24; 3(5):. PubMed ID: 30355669
    [Abstract] [Full Text] [Related]

  • 23. A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding.
    Yao G, Lam KH, Weisemann J, Peng L, Krez N, Perry K, Shoemaker CB, Dong M, Rummel A, Jin R.
    Sci Rep; 2017 Aug 07; 7(1):7438. PubMed ID: 28785006
    [Abstract] [Full Text] [Related]

  • 24. Synchronized chaperone function of botulinum neurotoxin domains mediates light chain translocation into neurons.
    Fischer A.
    Curr Top Microbiol Immunol; 2013 Aug 07; 364():115-37. PubMed ID: 23239351
    [Abstract] [Full Text] [Related]

  • 25. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor.
    Rummel A, Häfner K, Mahrhold S, Darashchonak N, Holt M, Jahn R, Beermann S, Karnath T, Bigalke H, Binz T.
    J Neurochem; 2009 Sep 07; 110(6):1942-54. PubMed ID: 19650874
    [Abstract] [Full Text] [Related]

  • 26. A Comprehensive Structural Analysis of Clostridium botulinum Neurotoxin A Cell-Binding Domain from Different Subtypes.
    Gregory KS, Acharya KR.
    Toxins (Basel); 2023 Jan 18; 15(2):. PubMed ID: 36828407
    [Abstract] [Full Text] [Related]

  • 27. Neuronal selectivity of botulinum neurotoxins.
    Poulain B, Lemichez E, Popoff MR.
    Toxicon; 2020 Apr 30; 178():20-32. PubMed ID: 32094099
    [Abstract] [Full Text] [Related]

  • 28. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells.
    Dong M, Richards DA, Goodnough MC, Tepp WH, Johnson EA, Chapman ER.
    J Cell Biol; 2003 Sep 29; 162(7):1293-303. PubMed ID: 14504267
    [Abstract] [Full Text] [Related]

  • 29. Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons.
    Dong M, Tepp WH, Liu H, Johnson EA, Chapman ER.
    J Cell Biol; 2007 Dec 31; 179(7):1511-22. PubMed ID: 18158333
    [Abstract] [Full Text] [Related]

  • 30. Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins.
    Tsukamoto K, Kohda T, Mukamoto M, Takeuchi K, Ihara H, Saito M, Kozaki S.
    J Biol Chem; 2005 Oct 21; 280(42):35164-71. PubMed ID: 16115873
    [Abstract] [Full Text] [Related]

  • 31. Receptor binding enables botulinum neurotoxin B to sense low pH for translocation channel assembly.
    Sun S, Suresh S, Liu H, Tepp WH, Johnson EA, Edwardson JM, Chapman ER.
    Cell Host Microbe; 2011 Sep 15; 10(3):237-47. PubMed ID: 21925111
    [Abstract] [Full Text] [Related]

  • 32. Enhancing the protective immune response against botulism.
    Przedpelski A, Tepp WH, Kroken AR, Fu Z, Kim JJ, Johnson EA, Barbieri JT.
    Infect Immun; 2013 Jul 15; 81(7):2638-44. PubMed ID: 23670557
    [Abstract] [Full Text] [Related]

  • 33. Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain.
    Pellett S, Tepp WH, Bradshaw M, Kalb SR, Dykes JK, Lin G, Nawrocki EM, Pier CL, Barr JR, Maslanka SE, Johnson EA.
    mSphere; 2016 Jul 15; 1(1):. PubMed ID: 27303710
    [Abstract] [Full Text] [Related]

  • 34. Synaptic vesicle proteins: targets and routes for botulinum neurotoxins.
    Ahnert-Hilger G, Münster-Wandowski A, Höltje M.
    Curr Top Microbiol Immunol; 2013 Jul 15; 364():159-77. PubMed ID: 23239353
    [Abstract] [Full Text] [Related]

  • 35. Botulinum neurotoxin X lacks potency in mice and in human neurons.
    Gregg BM, Matsumura T, Wentz TG, Tepp WH, Bradshaw M, Stenmark P, Johnson EA, Fujinaga Y, Pellett S.
    mBio; 2024 Mar 13; 15(3):e0310623. PubMed ID: 38347673
    [Abstract] [Full Text] [Related]

  • 36. Cloning, high-level expression, single-step purification, and binding activity of His6-tagged recombinant type B botulinum neurotoxin heavy chain transmembrane and binding domain.
    Zhou Y, Singh BR.
    Protein Expr Purif; 2004 Mar 13; 34(1):8-16. PubMed ID: 14766296
    [Abstract] [Full Text] [Related]

  • 37. Botulinum Neurotoxins Can Enter Cultured Neurons Independent of Synaptic Vesicle Recycling.
    Pellett S, Tepp WH, Scherf JM, Johnson EA.
    PLoS One; 2015 Mar 13; 10(7):e0133737. PubMed ID: 26207366
    [Abstract] [Full Text] [Related]

  • 38. The long journey of botulinum neurotoxins into the synapse.
    Rummel A.
    Toxicon; 2015 Dec 01; 107(Pt A):9-24. PubMed ID: 26363288
    [Abstract] [Full Text] [Related]

  • 39. Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin.
    Weisemann J, Stern D, Mahrhold S, Dorner BG, Rummel A.
    Toxins (Basel); 2016 May 17; 8(5):. PubMed ID: 27196927
    [Abstract] [Full Text] [Related]

  • 40. Neutralization mechanism of human monoclonal antibodies against type B botulinum neurotoxin.
    Matsumura T, Kitamura M, Amatsu S, Yamaguchi A, Kobayashi N, Yutani M, Fujinaga Y.
    Microbiol Immunol; 2024 Oct 17; 68(10):348-358. PubMed ID: 39239735
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.